![]() AFP 2 weeks ago | Other | A$0.01 Per Share |
![]() AFP 19 Jun 2024 Paid | Interim | A$0.01 Per Share |
![]() AFP 16 Jun 2023 Paid | Interim | A$0.01 Per Share |
21 Nov 2024 Date | | - Cons. EPS | - EPS |
2 Aug 2024 Date | | - Cons. EPS | - EPS |
1 Aug 2024 Date | | - Cons. EPS | - EPS |
23 May 2024 Date | | - Cons. EPS | - EPS |
21 May 2024 Date | | - Cons. EPS | - EPS |
![]() AFP 2 weeks ago | Other | A$0.01 Per Share |
![]() AFP 19 Jun 2024 Paid | Interim | A$0.01 Per Share |
![]() AFP 16 Jun 2023 Paid | Interim | A$0.01 Per Share |
21 Nov 2024 Date | | - Cons. EPS | - EPS |
2 Aug 2024 Date | | - Cons. EPS | - EPS |
1 Aug 2024 Date | | - Cons. EPS | - EPS |
23 May 2024 Date | | - Cons. EPS | - EPS |
21 May 2024 Date | | - Cons. EPS | - EPS |
Drug Manufacturers - Specialty & Generic Industry | Healthcare Sector | Dr. Hartley Atkinson Ph.D. CEO | ASX Exchange | NZAFTE0001S4 ISIN |
New Zealand Country | 110 Employees | 18 Jun 2025 Last Dividend | - Last Split | - IPO Date |
AFT Pharmaceuticals Limited operates as a diverse healthcare and pharmaceutical company, extending its reach beyond its New Zealand origins to Australia, Asia, and other international markets. Since its inception in 1997, the company has focused on the development and commercialization of a wide array of pharmaceutical products. Headquartered in Auckland, New Zealand, AFT Pharmaceuticals has built a prominent presence in the healthcare industry, leveraging its extensive portfolio and expertise to address various health concerns while striving to improve patient outcomes across multiple territories.
AFT Pharmaceuticals Limited offers a broad spectrum of products catering to an array of health and wellness needs. These include: